Austin Powers' Steamroller: Lessons Learned to Benefit Patients with Congenital Heart Disease

Jonathan N Menachem1, Daniel Clark1, Ari Cedars2

  • 1Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.

Insights

Most providers recognize Fontan procedure patients will need heart failure treatment and heart transplants. However, many are unsure if specialized heart failure/heart transplant cardiologist evaluation is routinely necessary, revealing a care gap.

Area of Science:

  • Cardiology
  • Congenital Heart Disease
  • Advanced Cardiac Care

Background:

  • Patients with single-ventricle physiology palliated by the Fontan procedure face a complex, lifelong care trajectory.
  • A significant majority of healthcare providers anticipate future heart failure (HF) and the eventual need for heart transplantation (HT) in these patients.
  • Current training pathways for pediatric and adult cardiologists may not adequately prepare them for the specialized needs of Fontan survivors.

Discussion:

  • Despite anticipating HF/HT, most providers (69%) are undecided or disagree on the necessity of routine HF/HT cardiologist evaluation for Fontan patients.
  • This disconnect may stem from the absence of a formal HF/HT subspecialty within pediatric cardiology training.
  • Limited HF/HT training requirements for adult congenital heart disease (ACHD) providers and adult HF/HT cardiologists further exacerbate this issue.

Key Insights:

  • A substantial gap exists between the expected long-term outcomes for Fontan patients and the perceived need for specialized HF/HT care.
  • Providers caring for Fontan patients demonstrate incongruent preparation regarding the anticipated need for heart failure and heart transplant interventions.
  • The lack of standardized training pathways in HF/HT for CHD complicates the management of these complex patients.

Outlook:

  • There is a critical need to bridge the gap in provider understanding and training for the long-term management of Fontan survivors.
  • Developing integrated care models and specialized training for HF/HT in CHD is essential.
  • Future efforts should focus on aligning provider preparedness with the lifelong, complex care needs of single-ventricle patients post-Fontan.

Related Concept Videos

Heart Valves01:16

Heart Valves

The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
6.9K
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
80
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
42
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
60
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
43
Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart...
1.3K